Proteomics-based phenotypic classification of non-smallcell lung cancer

被引：0
|
作者：
Berkovska, O. [1 ]
Mermelekas, G. [1 ]
Orre, L. [1 ]
Lehtio, J. [1 ]
机构：
[1] Karolinska Inst, Oncol Pathol, Stockholm, Sweden
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1292
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2264P
引用
收藏
页码：S1163 / S1164
页数：2
相关论文
共 50 条
  • [21] Prediction of Lung Cancer risk: Validation study of Proteomics-based algorithm in Japanese population
    Nakamura, Yohko
    Michihata, Nobuaki
    Shibayama, Masaki
    Kaneko, Naoto
    Waga, Iwao
    Hippo, Yoshitaka
    CANCER SCIENCE, 2024, 115 : 346 - 346
  • [22] Common Co-activation of AXL and CDCP1 in EGFR-mutation-positive Non-smallcell Lung Cancer Associated With Poor Prognosis
    Karachaliou, Niki
    Chaib, Imane
    Cardona, Andres Felipe
    Berenguer, Jordi
    Bracht, Jillian Wilhelmina Paulina
    Yang, Jie
    Cai, Xueting
    Hu, Chunping
    Drozdowskyj, Ana
    Servat, Carles Codony
    Servat, Jordi Codony
    Ito, Masaoki
    Attili, Ilaria
    Aldeguer, Erika
    Capitan, Ana Gimenez
    Rodriguez, July
    Rojas, Leonardo
    Viteri, Santiago
    Molina-Vila, Miguel Angel
    Ou, Sai-Hong Ignatius
    Okada, Morihito
    Mok, Tony S.
    Bivona, Trever G.
    Ono, Mayumi
    Cui, Jean
    Ramon y Cajal, Santiago
    Cao, Peng
    Rosell, Rafael
    EBIOMEDICINE, 2018, 29 : 112 - 127
  • [23] Enabling proteomics-based identification of human cancer variations
    Jing Li
    Zeqiang Ma
    Robbert JC Slebos
    David L Tabb
    Daniel C Liebler
    Bing Zhang
    BMC Bioinformatics, 11 (Suppl 4)
  • [24] Proteomics-Based Identification of Dysregulated Proteins in Breast Cancer
    Neagu, Anca-Narcisa
    Jayathirtha, Madhuri
    Whitham, Danielle
    Mutsengi, Panashe
    Sullivan, Isabelle
    Petre, Brindusa Alina
    Darie, Costel C.
    PROTEOMES, 2022, 10 (04)
  • [25] Proteomics-based identification of tumor relevant proteins in lung adenocarcinoma
    Zhou, Xin
    Xue, Liyan
    Hao, Lihong
    Liu, Shuqing
    Zhou, Fachen
    Xiong, Hai
    Qi, Xiaoyu
    Lin, Dongmei
    Shao, Shujuan
    BIOMEDICINE & PHARMACOTHERAPY, 2013, 67 (07) : 621 - 627
  • [26] Proteomics-based identification of secreted protein dihydrodiol dehydrogenase as a novel serum markers of non-small cell lung cancer
    Huang, Ling-Jin
    Chen, Sheng-Xi
    Huang, Yan
    Luo, Wan-Jun
    Jiang, Hai-He
    Hu, Qing-a Hu
    Zhang, Peng-Fei
    Yi, Hong
    LUNG CANCER, 2006, 54 (01) : 87 - 94
  • [27] ALK-Rearranged Non-SmallCell Lung Cancer in 2020:Real-WorldTriumphs in an Era of MultigenerationALK-InhibitorSequencing Informed by Drug Resistance Profiling
    Itchins, Malinda
    Lau, Brandon
    Hudson, Amanda L.
    Westman, Helen
    Xia, Cathy Yi
    Hayes, Sarah A.
    Howell, Viive M.
    Rodriguez, Michael
    Cooper, Wendy A.
    Wei, Heng
    Buckland, Michael
    Li, Bob T.
    Li, Mark
    Rathi, Vivek
    Fox, Stephen B.
    Gill, Anthony J.
    Clarke, Stephen J.
    Boyer, Michael J.
    Pavlakis, Nick
    ONCOLOGIST, 2020, 25 (08): : 641 - 649
  • [28] Elective nodal Irradiation (ENI) or non-Elective nodal irradiation in the treatment of non-smallcell lung cancer with three dimensional conformal radiotherapy (3D-CRT)
    Santoro, M.
    Durante, O.
    Scalzo, G.
    Pingitore, D.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 104 - 104
  • [29] Identification of biomarkers for colorectal cancer through proteomics-based approaches
    Tjalsma, Harold
    EXPERT REVIEW OF PROTEOMICS, 2010, 7 (06) : 879 - 895
  • [30] MiR-488 inhibits proliferation and cisplatin sensibility in non-smallcell lung cancer (NSCLC) cells by activating the eIF3a-mediated NER signaling pathway
    Fang, Chao
    Chen, Yi-Xin
    Wu, Na-Yiyuan
    Yin, Ji-Ye
    Li, Xiang-Ping
    Huang, Hsuan-Shun
    Zhang, Wei
    Zhou, Hong-Hao
    Liu, Zhao-Qian
    SCIENTIFIC REPORTS, 2017, 7
12345